Charles Schwab
SRTA

Charles Schwab’s Strata Critical Medical Inc SRTA Stock Holding History

Charles Schwab’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15M Buy
219,092
+17,284
+9% +$90.9K ﹤0.01% 2968
2026
Q1 		$844K Buy
201,808
+6,892
+4% +$33.2K ﹤0.01% 2948
2025
Q4 		$938K Buy
194,916
+7,026
+4% +$34K ﹤0.01% 2943
2025
Q3 		$951K Hold
187,890
– – ﹤0.01% 2965
2025
Q2 		$757K Buy
187,890
+18,447
+11% +$60K ﹤0.01% 2991
2025
Q1 		$463K Hold
169,443
– – ﹤0.01% 3105
2024
Q4 		$720K Sell
169,443
-674
-0.4% -$2.57K ﹤0.01% 3026
2024
Q3 		$500K Buy
170,117
+10,272
+6% +$32.7K ﹤0.01% 3163
2024
Q2 		$556K Buy
159,845
+2,107
+1% +$7.03K ﹤0.01% 3150
2024
Q1 		$450K Sell
157,738
-10,595
-6% -$32.7K ﹤0.01% 3068
2023
Q4 		$594K Hold
168,333
– – ﹤0.01% 3009
2023
Q3 		$436K Buy
168,333
+8,589
+5% +$30.2K ﹤0.01% 3090
2023
Q2 		$629K Buy
159,744
+1,632
+1% +$5.18K ﹤0.01% 2947
2023
Q1 		$534K Buy
158,112
+13,624
+9% +$55.5K ﹤0.01% 2928
2022
Q4 		$517K Buy
144,488
+3,614
+3% +$15.4K ﹤0.01% 2998
2022
Q3 		$568K Sell
140,874
-151
-0.1% -$776 ﹤0.01% 2966
2022
Q2 		$629K Buy
141,025
+123,296
+695% +$890K ﹤0.01% 2975
2022
Q1 		$151K Sell
17,729
-350
-2% -$2.46K ﹤0.01% 3352
2021
Q4 		$160K Hold
18,079
– – ﹤0.01% 3390
2021
Q3 		$189K Hold
18,079
– – ﹤0.01% 3336
2021
Q2 		$190K Buy
+18,079
New +$178K ﹤0.01% 3271

Other funds holding SRTA

TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $366M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab's SRTA Position: Q2 2026 in Review

Charles Schwab increased its Strata Critical Medical Inc (SRTA) stake by 8.6% in Q2 2026, buying an estimated $90.9K and bringing the position to 219,092 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #2968.

Charles Schwab first reported a position in SRTA in Q2 2021 and has held it in 21 quarters since. 139 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Charles Schwab held 219,092 shares of Strata Critical Medical Inc worth $1.15M as of Q2 2026.
  • Charles Schwab bought 17,284 Strata Critical Medical Inc shares in Q2 2026, an estimated $90.9K.
  • Strata Critical Medical Inc made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2968 holding.
  • Charles Schwab first reported a position in Strata Critical Medical Inc in Q2 2021 and has held it in 21 quarters since.
  • 139 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.